Colin Pearce

752 total citations
10 papers, 173 citations indexed

About

Colin Pearce is a scholar working on Cardiology and Cardiovascular Medicine, Clinical Biochemistry and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Colin Pearce has authored 10 papers receiving a total of 173 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cardiology and Cardiovascular Medicine, 6 papers in Clinical Biochemistry and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Colin Pearce's work include Advanced Glycation End Products research (6 papers), Antiplatelet Therapy and Cardiovascular Diseases (3 papers) and Natural Antidiabetic Agents Studies (2 papers). Colin Pearce is often cited by papers focused on Advanced Glycation End Products research (6 papers), Antiplatelet Therapy and Cardiovascular Diseases (3 papers) and Natural Antidiabetic Agents Studies (2 papers). Colin Pearce collaborates with scholars based in Canada. Colin Pearce's co-authors include Erick McNair, Kailash Prasad, C. Robert E. Wells, Mabood Qureshi, Adnan I. Qureshi, James McMeekin, Terence Moyana, John A. Sibley, Jennifer M. Arnold and Andrew Ignaszewski and has published in prestigious journals such as European Heart Journal, Molecular and Cellular Biochemistry and Canadian Journal of Cardiology.

In The Last Decade

Colin Pearce

9 papers receiving 172 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Colin Pearce Canada 7 128 73 49 26 20 10 173
H. Maillard-Lefebvre France 5 195 1.5× 81 1.1× 21 0.4× 34 1.3× 53 2.6× 7 288
Tsutomu Imaizumi Japan 3 29 0.2× 25 0.3× 55 1.1× 13 0.5× 12 0.6× 3 162
Jenny Söderlund Finland 6 84 0.7× 102 1.4× 12 0.2× 9 0.3× 16 0.8× 7 159
J Tatoń Poland 8 31 0.2× 109 1.5× 64 1.3× 12 0.5× 96 4.8× 36 287
Sanam Ebtehaj United States 6 32 0.3× 94 1.3× 36 0.7× 4 0.2× 16 0.8× 9 200
Július Gelžinský Czechia 8 23 0.2× 26 0.4× 64 1.3× 6 0.2× 12 0.6× 19 115
Yvo H. A. M. Kusters Netherlands 10 22 0.2× 76 1.0× 76 1.6× 6 0.2× 7 0.3× 16 260
Ron T. Gansevoort Netherlands 6 17 0.1× 32 0.4× 45 0.9× 26 1.0× 80 4.0× 17 233
M Assayag France 7 27 0.2× 87 1.2× 48 1.0× 3 0.1× 50 2.5× 10 240
Guido Cruciani Italy 6 26 0.2× 55 0.8× 7 0.1× 32 1.2× 25 1.3× 6 279

Countries citing papers authored by Colin Pearce

Since Specialization
Citations

This map shows the geographic impact of Colin Pearce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colin Pearce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colin Pearce more than expected).

Fields of papers citing papers by Colin Pearce

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Colin Pearce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colin Pearce. The network helps show where Colin Pearce may publish in the future.

Co-authorship network of co-authors of Colin Pearce

This figure shows the co-authorship network connecting the top 25 collaborators of Colin Pearce. A scholar is included among the top collaborators of Colin Pearce based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Colin Pearce. Colin Pearce is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Shavadia, Jay, Udoka Okpalauwaekwe, Minyoung Kim, et al.. (2024). Contemporary Outcomes of Acute Coronary Syndromes in Indigenous Compared With Non-Indigenous Patients: A Northern Saskatchewan Perspective. Canadian Journal of Cardiology. 40(11). 2094–2101.
2.
Shavadia, Jay, et al.. (2020). METFORMIN CONTINUATION VERSUS INTERRUPTION FOLLOWING CORONARY ANGIOGRAPHY: CONTEMPORARY RISK OF LACTIC ACIDOSIS. A PILOT SINGLE-CENTER RANDOMIZED CONTROL TRIAL. Canadian Journal of Cardiology. 36(10). S112–S113. 1 indexed citations
3.
Pearce, Colin, et al.. (2018). Advanced Glycation End Products:Receptors for Advanced Glycation End Products Axis in Coronary Stent Restenosis: A Prospective Study. International Journal of Angiology. 27(4). 213–222. 4 indexed citations
4.
Qureshi, Mabood, Kailash Prasad, Colin Pearce, & Erick McNair. (2016). Atherosclerosis and the Hypercholesterolemic AGE–RAGE Axis. International Journal of Angiology. 25(2). 110–116. 36 indexed citations
5.
Arnold, Jennifer M., Andrew Ignaszewski, Martine Leblanc, et al.. (2013). Ten year survival by NYHA functional class in heart failure outpatients referred to specialized multidisciplinary heart failure clinics 1999 to 2011. European Heart Journal. 34(suppl 1). P1505–P1505. 9 indexed citations
6.
7.
McNair, Erick, et al.. (2010). Modulation of high sensitivity C-reactive protein by soluble receptor for advanced glycation end products. Molecular and Cellular Biochemistry. 341(1-2). 135–138. 21 indexed citations
8.
McNair, Erick, et al.. (2010). Soluble Receptors for Advanced Glycation End Products (sRAGE) as a Predictor of Restenosis Following Percutaneous Coronary Intervention. Clinical Cardiology. 33(11). 678–685. 40 indexed citations
9.
McNair, Erick, et al.. (2009). Low levels of soluble receptor for advanced glycation end products in non-ST elevation myocardial infarction patients. International Journal of Angiology. 18(4). 187–192. 45 indexed citations
10.
Pearce, Colin, James McMeekin, Terence Moyana, & John A. Sibley. (1999). A case of peripartum eosinophilic myocarditis.. PubMed. 15(4). 465–8. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H. Maillard-Lefebvre Breakdown of academic impact, for papers by Tsutomu Imaizumi Breakdown of academic impact, for papers by Jenny Söderlund Breakdown of academic impact, for papers by J Tatoń Breakdown of academic impact, for papers by Sanam Ebtehaj Breakdown of academic impact, for papers by Július Gelžinský Breakdown of academic impact, for papers by Yvo H. A. M. Kusters Breakdown of academic impact, for papers by Ron T. Gansevoort Breakdown of academic impact, for papers by M Assayag Breakdown of academic impact, for papers by Guido Cruciani
Rankless by CCL
2026